A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
Status:
Recruiting
Trial end date:
2028-07-05
Target enrollment:
Participant gender:
Summary
This is an open-label, multicenter, extension study. Patients who are receiving clinical
benefit from atezolizumab monotherapy or atezolizumab in combination with other agent(s) or
comparator agent(s) during participation in a Genentech or Roche-sponsored study (the parent
study), who are eligible to continue treatment and who do not have access to the study
treatment locally, may continue to receive study treatment in this extension study following
roll-over from the parent study.